A user inquired about using TB-500 and BPC-157 to treat limited dorsiflexion and chronic pain caused by a non-healed broken ankle from ten years prior. While they ordered the peptides to address various general aches, they expressed skepticism that the treatment could fix what they described as a structural problem rather than an acute injury.